Maschauer, S.; Ruckdeschel, T.; Tripal, P.; Haubner, R.; Einsiedel, J.; Hübner, H.; Gmeiner, P.; Kuwert, T.; Prante, O.
In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study. Pharmaceuticals 2014, 7, 464-481.
https://doi.org/10.3390/ph7040464
AMA Style
Maschauer S, Ruckdeschel T, Tripal P, Haubner R, Einsiedel J, Hübner H, Gmeiner P, Kuwert T, Prante O.
In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study. Pharmaceuticals. 2014; 7(4):464-481.
https://doi.org/10.3390/ph7040464
Chicago/Turabian Style
Maschauer, Simone, Tina Ruckdeschel, Philipp Tripal, Roland Haubner, Jürgen Einsiedel, Harald Hübner, Peter Gmeiner, Torsten Kuwert, and Olaf Prante.
2014. "In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study" Pharmaceuticals 7, no. 4: 464-481.
https://doi.org/10.3390/ph7040464
APA Style
Maschauer, S., Ruckdeschel, T., Tripal, P., Haubner, R., Einsiedel, J., Hübner, H., Gmeiner, P., Kuwert, T., & Prante, O.
(2014). In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study. Pharmaceuticals, 7(4), 464-481.
https://doi.org/10.3390/ph7040464